Key Takeaway: Alvotech has filed two documents with the Luxembourg CSSF, detailing transactions involving managers and closely associated persons. The filings announce the pledging of 88,940,619 shares and 7,007,321 depository receipts on shares by Celtic. This disclosure is part of regulatory compliance regarding share transactions.
Price reaction · baseline $3.61 (2026-07-02 close) · hit after-hours · clean, no other ALVO news in the window
day 0 close · peak
-4.2%
Market Sentiment Analysis
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+128%
120-day peak, hindsight
Typical move
13.8%
average across 7 past catalysts
Lead asset
Stelara
Phase 3 · Psoriasis
Full Press Release Details
Attached are copies of two filings with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons, announcing the pledging of (i) 88,940,619 shares and (ii) 7,007,321 depository receipts on shares in Alvotech by Celtic
Frequently Asked Questions
What transactions were disclosed by Alvotech?
Alvotech disclosed the pledging of 88,940,619 shares and 7,007,321 depository receipts.
Who filed the transactions with the CSSF?
The transactions were filed by Alvotech with the Luxembourg CSSF.
What is the role of Celtic in these transactions?
Celtic is involved in the pledging of shares and depository receipts in Alvotech.
What regulatory body received the filings?
The filings were submitted to the Luxembourg Commission de Surveillance du Secteur Financier (CSSF).